background

Vaccines

Precision at Scale: Secure Your Vaccine Global Supply Chain

Vaccines

Vaccine programs demand flawless execution at unprecedented scale, yet outsourcing to high-volume facilities introduces risks: lot variability, cold chain breaks, and aseptic breaches that can compromise immunogenicity or trigger recalls.

Aventiq Bio acts as your reliability guardian - delivering independent oversight for antigen integrity, fill-finish mastery, and global access in India's dominant ecosystem.

    India's Vaccine Dominance – Scale with Precision Potential

    India's facilities are unrivaled for volume, with WHO-prequalified sites producing recombinant, subunit, viral vector, and live/attenuated vaccines at billion-dose levels. Strengths include robust cold chain networks, adjuvant expertise, and rapid response capability. The ecosystem supports global tenders and emerging innovations including mRNA vaccine platforms and adjuvanted subunit technologies.

  • Lot-to-Lot Consistency Variability

    Batch #1 differing from Batch #100 in potency or impurities at massive scale.

  • Thermal Stability Profiles

    Antigen degradation during storage/transport in diverse climates                            

  • Aseptic Integrity at Speed

    High-speed lines (600+ vials/min) prone to subtle sterility breaches missed in routine audits.

  • Adjuvant-Antigen Compatibility Issues

    Poor integration leading to reduced immunogenicity or stability.                    

  • Analytical Bridge to Potency

    In-vitro assays failing to correlate with clinical immune responses                                       

about

 

Protecting Potency at Every Transition

We organize oversight around three pillars - ensuring reliability from antigen to global distribution.

Antigen IntegrityExpression System Optimization

  • Oversight of CHO, yeast, or bacterial platforms for subunit/recombinant antigens
  • Adjuvant-antigen compatibility and immunogenicity advisory

Fill-Finish Mastery High-Speed Aseptic Governance

  • On-ground "Person-in-Plant" monitoring of sterile lines
  • Cold-chain stress testing and secondary packaging validation

Global Access WHO Prequalification Support

  • Site Master File (SMF) audit and dossier alignment
  • Viral clearance validation and analytical bridge to potency



  • The Aventiq Edge (in bold): Early potency correlation planning to avoid clinical surprises

Why Aventiq Bio – Your Vaccine Reliability Guardian

Many potent peptides fall under HPAPI classification (OEB 4–5 due to cytotoxicity). We extend our extreme containment expertise to these programs, ensuring safe synthesis, scale-up, and integration - particularly for oncology and ADC applications.

    Deep expertise in India's WHO-prequalified, high-volume facilities

    Proven lot-to-lot consistency and cold chain programs

    On-ground aseptic specialists for real-time intervention

    True independence — focused on your vaccine's global impact

    Track record supporting recombinant, subunit, and viral vector vaccines

All engagements are confidential. No information is shared without written consent.
×

Search

Press Enter to search